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Abstract
Systemic lupus erythematosus (SLE) is a multisystem, autoimmune disor-
der that can have numerous ocular manifestations, which may precede or 
occur upon initial presentation of SLE. We report on a 72-year-old woman 
with peripheral corneal perforation but without any predisposing factors. 
SLE was diagnosed because of signs and symptoms such as arthritis, leu-
kopenia, anemia, positive anti-dsDNA antibody, and positive antinuclear 
antibody (ANA). Systemic therapy with oral hydroxylchloroquine 200 mg 
daily was prescribed. Therapeutic penetrating keratoplasty with cryopre-
served cornea was also performed to repair the perforated cornea. Six 
months postoperatively, the corneal lesion became scarred and her visual 
acuity improved from 2/200 to 20/70 without any ocular or systemic 
recurrence. [Tzu Chi Med J 2009;21(2):169–171]
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1. Introduction
Systemic lupus erythematosus (SLE) is a multisys-
tem, autoimmune disorder that can have numerous 
ocular manifestations, which may precede or occur 
upon initial presentation of SLE [1]. We report a pa-
tient whose ocular manifestations led to a diagnosis 
of SLE.
2. Case report
A 72-year-old woman visited our ophthalmologic clinic 
with continuous tearing of her left eye for 3 days. 
The patient denied any systemic disease, but re-
ported treatment for arthritis.
Upon examination, the visual acuity was 20/40 
in the right eye and 2/200 in the left eye. Left 
eye biomicroscopic examination revealed conjuncti-
val con gestion, peripheral corneal melting extending 
from the 3 o’clock to the 5 o’clock position with iris 
incarceration (Fig. 1), and a shallow anterior chamber. 
Nasal corneal punctate epitheliopathy was present 
in the right eye. Both eyes had moderate cataract 
and normal fundi. Right eye Schirmer test measured 
1 mm, while that of the left eye was asymmetrically 
11 mm, probably due to microleakage of aqueous hu-
mor. Peripheral ulcerative keratitis (PUK) with corneal 
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perforation of the left eye was diagnosed. A complete 
blood count revealed leukopenia and anemia. Rheu-
matologic studies disclosed positive antinuclear anti-
body (ANA), anti-dsDNA antibody, and anti-SSA and 
anti-SSB autoantibodies. Following a diagnosis of SLE, 
the patient began oral hydroxychloroquine 200 mg 
under the guidance of a rheumatologist.
Therapeutic penetrating keratoplasty with glycerol-
preserved cornea was performed to seal the corneal 
perforation. The source of the graft was the remnant 
of the donor cornea, which was supplied by eye banks 
either in Taiwan or USA, previously used during pen-
etrating keratoplasty at Chang Gung Memorial Hospital. 
Intraoperatively, perifocal infiltrate was scraped and 
sent for microbiologic investigation, which was later 
proved to be negative. Minimal debridement for the 
infiltrate was done owing to the less suppurative 
nature and for the purpose of being less destructive to 
the donor cornea. The glycerol-preserved cornea was 
cut to slightly oversize the perforation, approximately 
5 mm × 3 mm. Lamellar dissection of the graft was 
also executed for an applicable thickness. Eight inter-
rupted nylon sutures were used to secure the graft to 
the donor cornea. The postoperative course was un-
eventful. The patient was placed on a regimen of top-
ical 0.3% gentamicin solution four times daily, 0.5% 
atropine daily, and sustain-tears ointment twice daily. 
Corneal scarring without conjunctival hyperemia was 
noted 6 months postoperatively (Fig. 2). The best-
corrected visual acuity in the left eye was 20/70.
3. Discussion
PUK, a crescent-shaped destructive lesion of the jux-
talimbal corneal stroma, is associated with epithelial 
defect, presence of stromal inflammatory cells, and 
stromal degradation [2]. It can rapidly progress to 
necrosis of the corneal stroma, leading to perforation 
and blindness [3]. The extraocular significance of PUK 
is under-recognized, and approximately 50% of non-
infectious cases of PUK are associated with collagen 
vascular disease [1,2]. Thus, rheumatologic exami-
nations should be studied in such cases, as was in our 
patient. It is important to recognize and treat PUK 
in the setting of systemic connective tissue disease, 
because serious life-threatening vasculitis has been 
demonstrated in these patients [3], and appropriate 
immunosuppressive therapy is essential to prevent 
blindness and premature death [2,4].
SLE is an autoimmune disease associated with 
severe alterations in immune regulation. The disease 
is characterized by a great clinical diversity, including 
facial rash, discoid lupus, Raynaud’s phenomenon, 
alopecia, photosensitivity, oral and nasopharyngeal 
ulcers, non-deforming arthritis, nephritic syndrome, 
pleuritis, pericarditis, psychosis, convulsions, anemia, 
leukopenia and thrombocytopenia [5]. The diagnosis 
is based on meeting four out of 11 criteria, including 
abnormal results on laboratory tests recommended 
by the American Rheumatism Association [5]. The 
prevalence of ocular manifestations varies in unse-
lected patients, depending on the exacerbations and 
remissions of the condition [6]. External ocular find-
ings in SLE include keratoconjunctivitis sicca [6], su-
perficial punctate keratitis [7], interstitial keratitis 
[8,9], episcleritis [10], scleritis [11], and, rarely, PUK 
[1,2,8,12]. Although PUK in the setting of SLE is rare, 
it signifies advanced disease that requires systemic 
control of inflammation.
It is important to distinguish PUK associated with 
collagen vascular disease from infectious causes of 
Fig. 1 — Slit-lamp examination reveals conjunctival con-
gestion, peripheral corneal melting extending from the 
3 o’clock to the 5 o’clock position with iris incarceration, 
and a shallow anterior chamber in the left eye.
Fig. 2 — Corneal scarring without conjunctival hyperemia 
in the left eye 6 months postoperatively.
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peripheral keratitis and from Mooren’s ulcer. Any local 
ocular infection may be associated with peripheral 
corneal ulceration, such as herpes simplex virus (HSV) 
epithelial keratitis, which in normal host immune 
system will be confined to a paracentral distribution. 
In immunocompromised patients, it has a predilection 
for the limbus and is seen more commonly as mar-
ginal HSV [13]. Mooren’s ulcer is, by definition, idio-
pathic and therefore cannot be associated with any 
systemic disorder that could contribute to the corneal 
pathology. There are many systemic diseases that are 
associated with PUK. It has been described in patients 
with rheumatoid arthritis (RA), Wegener’s granulo-
matosis, relapsing polychondritis, SLE, classic polyar-
teritis nodosa, and its variants, microscopic polyangiitis 
and Churg-Strauss syndrome [11,14]. Among them, 
RA is the most common systemic disease associated 
with PUK [15,16]. In RA, corneal melting usually 
occurs in a patient with long-standing disease, that is, 
the same type of patient who is prone to the devel-
opment of rheumatoid vasculitis—nodular, erosive, 
and rheumatoid factor positive. Wegener’s granulo-
matosis also has a high rate of ocular involvement. 
In Wegener’s granulomatosis and other forms of sys-
temic vasculitis, corneal melting can occur earlier 
in the disease course. Regardless of the underlying 
condition, corneal melting can occur swiftly once in-
flammation begins within the cornea. Visual loss can 
ensue within days [15,16].
In our patient, arthritis, hematological disorder 
(leukopenia and anemia), immunological abnormality 
(positive anti-dsDNA antibody), and positive ANA led 
to a diagnosis of SLE. Secondary Sjögren’s syndrome 
was also diagnosed because of the abnormal Schirmer 
test, as well as positive anti-SSA and anti-SSB autoanti-
bodies. Systemic immune-mediated inflammation and 
an unstable corneal epithelium in secondary Sjögren’s 
syndrome are potential factors that trigger the process 
of corneal thinning and perforation [3].
The treatment of PUK is determined by the severity 
of findings within the cornea and the extent of exter-
nal ocular diseases [2,15]. Adequate control of PUK as 
well as other ophthalmic manifestations of SLE re-
quires the initiation of systemic immunosuppressive 
therapy. Surgical management of PUK is reserved for 
cases of impending perforation to preserve the integ-
rity of the globe. Options depend on the size of the 
perforation and include the use of a tissue adhesive 
bandage contact lens, lamellar keratoplasty, or pene-
trating keratoplasty. In our patient, therapeutic kerat-
oplasty and systemic hydroxychloroquine stopped 
the progression of PUK. The clinical success should 
be attributed to timely ophthalmic diagnosis and 
management as well as the less severe nature of the 
disease.
In conclusion, it is never overemphasized that cases 
of ulcerative keratitis with unknown causes merit 
systemic, especially rheumatologic, investigation in 
addition to ophthalmic measures, not only to salvage 
the patient’s sight but also to preserve their life.
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